A Study of PRT-201 Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-1)

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 349 participants.

Also called NCT02110901

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 349 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02110901
Other papers using this trial's data
  • A randomized trial of vonapanitase (PATENCY-1) to promote radiocephalic fistula patency and use for hemodialysis Journal of vascular surgery, 2019-02 DOI, PubMed 30683197 PubMed links an erratum for this paper. Erratum: PMID 30905372

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02110901. Randomized; quadruple masking; primary purpose treatment. Start 2014-07 (actual); primary completion 2016-12 (actual). Results posted on 2019-07-09.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study of PRT-201 Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-1)
Intervention (Drug)
PRT-201
Intervention (Drug)
Placebo
Lead sponsor
Proteon Therapeutics (class: industry)

Record details

Record id
cardio:ct-nct02110901
Content hash
f920e806126d0b9163a15442454a9cb4548469c8998e936d4dbadfc455dc0b80